Page 2 - Standard Biotools News Today

Standard BioTools Inc. (NASDAQ:LAB – Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $2.66, but opened at $2.80. Standard BioTools shares last traded at $2.80, with a volume of 388,749 shares trading hands. Analyst Ratings Changes Separately, Jefferies Financial Group began coverage on shares of […]

Equities Research Analysts’ new coverage for Thursday, April 4th: StockNews.com started coverage on shares of ARCA biopharma (NASDAQ:ABIO). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). The firm issued a buy rating on the stock. StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD). They […]

Standard BioTools Inc. ( NASDAQ:LAB ), might not be a large cap stock, but it led the NASDAQGS gainers with a...

Digital PCR (DPCR) Market Shows Exponential Growth by Revolutionizing molecular diagnostics through digital PCR technology

/PRNewswire/ -- Gene Expression Analysis Market in terms of revenue was estimated to be worth $4.2 billion in 2024 and is poised to reach $6.2 billion by 2029,...

Standard BioTools ( NASDAQ:LAB ) Full Year 2023 Results Key Financial Results Revenue: US$106.3m (up 8.6% from FY...

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.

Merger with SomaLogic Marks a Strategic Milestone for the Life Sciences Tools Provider

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that

Standard BioTools Inc. ( NASDAQ:LAB ) shareholders should be happy to see the share price up 14% in the last month. But...